A review of matched-sample benchmarking studies finds standard RNA-seq recovers only 3–5% of TCR clonotypes identified by ...
Researchers identified RNA-associated amyloid fibrils in human seminal fluid and demonstrated that synthetic PAP fibrils ...
A Nature Genetics analysis of GTEx tissues and seven phenotypes shows that annotation and quantification method choices ...
Rotow, MD, explains how RNA-based next-generation sequencing (NGS) fits into testing for newly diagnosed advanced nonsquamous non-small cell lung cancer (NSCLC) in a discussion moderated by Matthew A.
Tempus AI, Inc. (NASDAQ: TEM) today announced that its xR assay has received certification under the European Union’s In Vitro Diagnostic Regulation (IVDR) as a Class C in vitro diagnostic device. The ...
Tempus xR RNA sequencing assay receives EU IVDR Class C certification, supporting continued clinical and biopharma access in ...
When you start research using a Next-Generation Sequencer (NGS), one of the first problems you face is, "How many reads are ...
MassBio is partnering with the ElevateBio team on November 2 to host 2026 R&D Reimagined – Techbio Solutions, the second in a ...
Precision-cut lung slices allow researchers to study living human lung tissue outside the body, preserving the different cell ...
A research team led by distinguished professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University (Japan), has demonstrated that differences in the molecular structures ...
Single Cell RNA-seq (scRNAseq) analysis is a field in life sciences that has seen rapid technological innovation in recent ...
PACB partners with TychoBio to harness AI and long-read RNA sequencing for rare disease therapies, aiming to improve drug efficacy and safety through advanced data models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results